GPR84 agonist
This page covers all GPR84 agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GPR84.
Targets
Phase 2 pipeline (1)
- ALC-2203-2 · Korea Arlico Pharm. Co., Ltd · Inflammation
ALC-2203-2 is a selective and potent agonist of the GPR84 receptor.
Patent intelligence
- gpr84 agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates